>PDB:1atu:A/1-374 UNCLEAVED ALPHA-1-ANTITRYPSIN
PTFNKITPNLAEFAFSLYRQLAHQSNSTNILFSPVSIAAAFAMLSLGAKGDTHDEILEGLNFNLTEIPEAQI
HEGFQELLRTLNQPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGD-TEEAKKQINDYVEK
GTQGKIVDLVKE--LDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMMKRLGMFNIQHCK
K--LSSWVLLMKYLGNATAIFFLPDE-----GKLQHLENELTHDIITKFLENEDRRSAS--LHLPKLSITGT
YDLKSVLGQLGITKVFSNG-ADLSGVTEEAPLKLSKAVHKAVLTIDEKGTEAAGAMFLEAIPMSIPPEVKFN
KPFVFLIIEQNTKAPLFMGRVVNPTQK
>PDB:1as4:A/1-336 CLEAVED ANTICHYMOTRYPSIN A349R
----GLASANVDFAFSLYKQLVLKAPDKNVIFSPLSISTALAFLSLGAHNTTLTEILKGLKFNLTETSEAEI
HQSFQHLLRTLNQSSDELQLSMGNAMFVKEQLSLLDRFTEDAKRLYGSEAFATDFQD-SAAAKKLINDYVKN
GTRGKITDLIKD--LDSQTMMVLVNYIFFKAKWEMPFDPQDTHQSRFYLSKKKWVMVPMMSLH-HLTIPYFR
DEELSCTVVELKYTGNASALFILPDQ-----DKMEEVEAMLLPETLKRWRDSLEFREIG-ELYLPKFSISRD
YNLNDILLQLGIEEAFTSK-ADLSGITGARNLAVSQVVHKAVLDVFEEGTEASRATAVK-------------
---ITLL--------------------
>PDB:1by7:A/1-354 HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-2. LOOP (66-
---EDLCVANTLFALNLFKHLAKASPTQNLFLSPWSISSTMAMVYMGSRGSTEDQMAKVLQFNEVGAAD-KI
HSSFRSLSSAIN------LLESVNKLFGEKSASFREEYIRLCQKYYSSEPQAVDFLECAEEARKKINSWVKT
QTKGKIPNLLPEGSVDGDTRMVLVNAVYFKGKWKTPFEKK---LYPFRVNSAQRTPVQMMYLREKLNIGYIE
D--LKAQILELPYAGDVSMFLLLPDEIADVSTGLELLESEITYDKLNKWTSKDKMAEDEVEVYIPQFKLEEH
YELRSILRSMGMEDAFNKGRANFSGMSERNDLFLSEVFHQAMVDVNEEGT---GPQFVA------------D
HPFLFLIMHKITNCILFFGRFSSP---
